Metodura

Metoprolol Tartrate, the active ingredient in Metodura, is a beta‑adrenergic blocker presented as an oral dosage form for oral use. It is employed to manage high blood pressure, angina, post‑myocardial infarction care, chronic heart failure, and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metodura as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Our distribution network ensures timely delivery and compliance with local regulatory requirements.

Metodura (metoprolol tartrate) is a selective β1‑adrenergic blocker used in cardiovascular disease management.

- Hypertension: lowers systolic and diastolic pressure, reducing overall cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain episodes. - Post‑myocardial infarction: helps prevent recurrent ischemic events and improves survival. - Chronic heart failure: improves ventricular function and reduces hospitalisation rates. - Cardiac arrhythmias: controls heart rate in supraventricular tachyarrhythmias and atrial fibrillation.

Metodura may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Fatigue: feeling of tiredness or reduced energy. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced peripheral circulation. - Gastrointestinal upset: nausea, abdominal discomfort. - Depression: mood changes or low spirits.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to fainting or shock. - Bronchospasm in patients with reactive airway disease. - Allergic reactions such as rash, itching, or angioedema. - Acute heart failure exacerbation. - Cardiogenic shock in rare cases.

Before initiating Metodura, clinicians should consider several safety measures.

- Monitor blood pressure: check regularly during initiation and dose adjustments. - Assess heart rate: watch for bradycardia, especially in patients with pre‑existing conduction disorders. - Caution in asthma/COPD: β‑blockade may worsen bronchospasm. - Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. - Use with caution in diabetes: may mask hypoglycaemia symptoms. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

Metodura can interact with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Calcium channel blockers (verapamil, diltiazem): risk of severe atrioventricular block. - Clonidine: abrupt withdrawal may cause rebound hypertension.

Moderate Interactions (Monitor Closely): - Non‑selective beta‑blockers: additive bradycardia. - Insulin or oral hypoglycemics: may mask signs of hypoglycaemia. - Potassium‑sparing diuretics: increased risk of hyperkalaemia.